The Clinical Trial Conundrum for Gynecologic Cancers

Affiliations

¹ Laura J. Havrilesky and Hayley A. Moss are from the Department of Obstetrics and Gynecology at the Duke University Medical Center, Durham, North Carolina; havri001@mc.duke.edu.

Editorial

Laura J Havrilesky et al. Obstet Gynecol. 2023.

. 2023 Sep 1;142(3):457-458.

doi: 10.1097/AOG.0000000000005307. Epub 2023 Aug 3.

¹ Laura J. Havrilesky and Hayley A. Moss are from the Department of Obstetrics and Gynecology at the Duke University Medical Center, Durham, North Carolina; havri001@mc.duke.edu.

No abstract available

Conflict of interest statement

Financial Disclosure The authors did not report any potential conflicts of interest.

Association of Clinical Trial Participation With Improved Overall Survival for Recurrent, Platinum-Resistant Ovarian Cancer.
Morton M, Yao M, Chalif J, Lampert EJ, Chau D, Rose PG, Debernardo R, Michener CM, Vargas R, Chambers LM. Morton M, et al. Obstet Gynecol. 2023 Sep 1;142(3):459-466. doi: 10.1097/AOG.0000000000005298. Obstet Gynecol. 2023. PMID: 37535957
Large Publication Gap for Gynecologic Cancers in High-Impact Factor Journals.
Sinha N, McDonald A, Barry D, Barber EL. Sinha N, et al. Obstet Gynecol. 2023 Sep 1;142(3):467-475. doi: 10.1097/AOG.0000000000005301. Obstet Gynecol. 2023. PMID: 37535969

1. Morton M, Yao M, Chalif J, Lampert EJ, Chao D, Rose PG, et al. Association of clinical trial participation with improved overall survival for recurrent, platinum-resistant ovarian cancer. Obstet Gynecol 2023;142:459–466. doi: 10.1097/AOG.0000000000005298 - DOI
1. Sinha N, McDonald A, Barry D, Barber E. Large publication gap for gynecologic cancers in high–impact factor journals. Obstet Gynecol 2023;142:467–475. doi: 10.1097/AOG.0000000000005301 - DOI
1. Robinson WR, Ritter J, Rogers AS, Tedjarati S, Lieberenz C. Clinical trial participation is associated with improved outcome in women with ovarian cancer. Int J Gynecol Cancer 2009;19:124–8. doi: 10.1111/IGJ.0b013e31819a1ce8 - DOI
1. Nitecki R, Bercow AS, Gockley AA, Lee H, Penson RT, Growdon WB. Clinical trial participation and aggressive care at the end of life in patients with ovarian cancer. Int J Gynecol Cancer 2020;30:201–6. doi: 10.1136/ijgc-2019-000851 - DOI
1. Peppercorn JM, Weeks JC, Cook EF, Joffe S. Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. The Lancet 2004;363:263–70. doi: 10.1016/S0140-6736(03)15383-4 - DOI